Skip to content
healthcare.dev

Thiotepa

NDC 25021-246, Thiotepa, injection, powder, lyophilized, for solution, from Sagent Pharmaceuticals.

Product NDC
25021-246
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209150
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-246 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THIOTEPA15 mg/1.5mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
25021-246-02250210246021 VIAL in 1 CARTON (25021-246-02) / 1.5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/448c29f1-6d9c-4f8e-8a69-9b85e973e728
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-246

Use it

Look up 25021-246 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-246 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-246. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.